Hsu KC - Search Results

1

KIR3DL1 and HLA-B Density and Binding Calibrate NK Education and Response to HIV.

Boudreau JE, Mulrooney TJ, Le Luduec JB, Barker E, Hsu KC. Boudreau JE, et al. Among authors: hsu kc. J Immunol. 2016 Apr 15;196(8):3398-410. doi: 10.4049/jimmunol.1502469. Epub 2016 Mar 9. J Immunol. 2016. PMID: 26962229 Free PMC article.

2

Killer Ig-like receptor haplotype analysis by gene content: evidence for genomic diversity with a minimum of six basic framework haplotypes, each with multiple subsets.

Hsu KC, Liu XR, Selvakumar A, Mickelson E, O'Reilly RJ, Dupont B. Hsu KC, et al. J Immunol. 2002 Nov 1;169(9):5118-29. doi: 10.4049/jimmunol.169.9.5118. J Immunol. 2002. PMID: 12391228

3

Inhibitory killer Ig-like receptor genes and human leukocyte antigen class I ligands in haematopoietic stem cell transplantation.

Dupont B, Hsu KC. Dupont B, et al. Among authors: hsu kc. Curr Opin Immunol. 2004 Oct;16(5):634-43. doi: 10.1016/j.coi.2004.07.013. Curr Opin Immunol. 2004. PMID: 15342011 Review.

4

KIR2DS1-positive NK cells mediate alloresponse against the C2 HLA-KIR ligand group in vitro.

Chewning JH, Gudme CN, Hsu KC, Selvakumar A, Dupont B. Chewning JH, et al. Among authors: hsu kc. J Immunol. 2007 Jul 15;179(2):854-68. doi: 10.4049/jimmunol.179.2.854. J Immunol. 2007. PMID: 17617576

5

Hierarchy of the human natural killer cell response is determined by class and quantity of inhibitory receptors for self-HLA-B and HLA-C ligands.

Yu J, Heller G, Chewning J, Kim S, Yokoyama WM, Hsu KC. Yu J, et al. Among authors: hsu kc. J Immunol. 2007 Nov 1;179(9):5977-89. doi: 10.4049/jimmunol.179.9.5977. J Immunol. 2007. PMID: 17947671

6

Breaking tolerance to self, circulating natural killer cells expressing inhibitory KIR for non-self HLA exhibit effector function after T cell-depleted allogeneic hematopoietic cell transplantation.

Yu J, Venstrom JM, Liu XR, Pring J, Hasan RS, O'Reilly RJ, Hsu KC. Yu J, et al. Among authors: hsu kc. Blood. 2009 Apr 16;113(16):3875-84. doi: 10.1182/blood-2008-09-177055. Epub 2009 Jan 28. Blood. 2009. PMID: 19179302 Free PMC article.

7

Unlicensed NK cells target neuroblastoma following anti-GD2 antibody treatment.

Tarek N, Le Luduec JB, Gallagher MM, Zheng J, Venstrom JM, Chamberlain E, Modak S, Heller G, Dupont B, Cheung NK, Hsu KC. Tarek N, et al. Among authors: hsu kc. J Clin Invest. 2012 Sep;122(9):3260-70. doi: 10.1172/JCI62749. Epub 2012 Aug 6. J Clin Invest. 2012. PMID: 22863621 Free PMC article.

8

HLA-C-dependent prevention of leukemia relapse by donor activating KIR2DS1.

Venstrom JM, Pittari G, Gooley TA, Chewning JH, Spellman S, Haagenson M, Gallagher MM, Malkki M, Petersdorf E, Dupont B, Hsu KC. Venstrom JM, et al. Among authors: hsu kc. N Engl J Med. 2012 Aug 30;367(9):805-16. doi: 10.1056/NEJMoa1200503. N Engl J Med. 2012. PMID: 22931314 Free PMC article.

9

NK cell tolerance of self-specific activating receptor KIR2DS1 in individuals with cognate HLA-C2 ligand.

Pittari G, Liu XR, Selvakumar A, Zhao Z, Merino E, Huse M, Chewning JH, Hsu KC, Dupont B. Pittari G, et al. Among authors: hsu kc. J Immunol. 2013 May 1;190(9):4650-60. doi: 10.4049/jimmunol.1202120. Epub 2013 Apr 3. J Immunol. 2013. PMID: 23554313 Free PMC article.

10

Development of a novel multiplex PCR assay to detect functional subtypes of KIR3DL1 alleles.

Boudreau JE, Le Luduec JB, Hsu KC. Boudreau JE, et al. Among authors: hsu kc. PLoS One. 2014 Jun 11;9(6):e99543. doi: 10.1371/journal.pone.0099543. eCollection 2014. PLoS One. 2014. PMID: 24919192 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

555 results

Search Page

Filters